129 related articles for article (PubMed ID: 38477985)
21. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
[TBL] [Abstract][Full Text] [Related]
22. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
23. [Screening of colorectal cancer in Kunming urban residents from 2014 to 2017].
Zhou H; Zhang X; Shen ZH; Chen XB; Zhao GQ; Lin YP; Huang YC; Zhang Q; Ma J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1058-1063. PubMed ID: 31770837
[No Abstract] [Full Text] [Related]
24. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
[TBL] [Abstract][Full Text] [Related]
25. Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study.
Imperiale TF; Monahan PO; Stump TE; Glowinski EA; Ransohoff DF
Ann Intern Med; 2015 Sep; 163(5):339-46. PubMed ID: 26259154
[TBL] [Abstract][Full Text] [Related]
26. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy.
Collins MG; Teo E; Cole SR; Chan CY; McDonald SP; Russ GR; Young GP; Bampton PA; Coates PT
BMJ; 2012 Jul; 345():e4657. PubMed ID: 22833618
[TBL] [Abstract][Full Text] [Related]
27. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
[TBL] [Abstract][Full Text] [Related]
28. Impact of subsequent screening episodes on the positive predictive value for advanced neoplasia and on the distribution of anatomic subsites of colorectal cancer: A population-based study on behalf of the French colorectal cancer screening program.
Azimafoussé Assogba GF; Jezewski-Serra D; Lastier D; Quintin C; Denis B; Beltzer N; Duport N
Cancer Epidemiol; 2015 Dec; 39(6):964-71. PubMed ID: 26546750
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
[TBL] [Abstract][Full Text] [Related]
30. Randomized Trial of Facilitated Adherence to Screening Colonoscopy vs Sequential Fecal-Based Blood Test.
Zauber AG; Winawer SJ; O'Brien MJ; Mills GM; Allen JI; Feld AD; Jordan PA; Fleisher M; Orlow I; Meester RGS; Lansdorp-Vogelaar I; Rutter CM; Knudsen AB; Mandelson M; Shaukat A; Mendelsohn RB; Hahn AI; Lobaugh SM; Soto Palmer B; Serrano V; Kumar JR; Fischer SE; Chen JC; Bayuga-Miller S; Kuk D; O'Connell K; Church TR
Gastroenterology; 2023 Jul; 165(1):252-266. PubMed ID: 36948424
[TBL] [Abstract][Full Text] [Related]
31. A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screening.
Sun Q; Pastor L; Du J; Powell MJ; Zhang A; Bodmer W; Wu J; Zheng S; Sha MY
PLoS One; 2021; 16(10):e0244332. PubMed ID: 34610014
[TBL] [Abstract][Full Text] [Related]
32. Counting Advanced Precancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test Specificity.
Ladabaum U; Church TR; Feng Z; Ransohoff DF; Schoen RE
J Natl Cancer Inst; 2022 Jul; 114(7):1040-1043. PubMed ID: 35134969
[TBL] [Abstract][Full Text] [Related]
33. Tumor-associated DNA mutation detection in individuals undergoing colonoscopy.
Fleshner P; Braunstein GD; Ovsepyan G; Tonozzi TR; Kammesheidt A
Cancer Med; 2018 Jan; 7(1):167-174. PubMed ID: 29125240
[TBL] [Abstract][Full Text] [Related]
34. A novel multitarget stool DNA test for colorectal cancer screening.
Malik P
Postgrad Med; 2016; 128(2):268-72. PubMed ID: 26753807
[TBL] [Abstract][Full Text] [Related]
35. Circulating free DNA in a screening program for early colorectal cancer detection.
Perrone F; Lampis A; Bertan C; Verderio P; Ciniselli CM; Pizzamiglio S; Frattini M; Nucifora M; Molinari F; Gallino G; Gariboldi M; Meroni E; Leo E; Pierotti MA; Pilotti S
Tumori; 2014; 100(2):115-21. PubMed ID: 24852853
[TBL] [Abstract][Full Text] [Related]
36. The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants.
Kværner AS; Birkeland E; Bucher-Johannessen C; Vinberg E; Nordby JI; Kangas H; Bemanian V; Ellonen P; Botteri E; Natvig E; Rognes T; Hovig E; Lyle R; Ambur OH; de Vos WM; Bultman S; Hjartåker A; Landberg R; Song M; Blix HS; Ursin G; Randel KR; de Lange T; Hoff G; Holme Ø; Berstad P; Rounge TB
BMC Cancer; 2021 Aug; 21(1):930. PubMed ID: 34407780
[TBL] [Abstract][Full Text] [Related]
37. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
[TBL] [Abstract][Full Text] [Related]
39. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial.
Stoop EM; de Haan MC; de Wijkerslooth TR; Bossuyt PM; van Ballegooijen M; Nio CY; van de Vijver MJ; Biermann K; Thomeer M; van Leerdam ME; Fockens P; Stoker J; Kuipers EJ; Dekker E
Lancet Oncol; 2012 Jan; 13(1):55-64. PubMed ID: 22088831
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]